X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    NHS Acquires Potentially Lifesaving Breast Cancer Medication

    Transfusion of The First Patients Lab-Grown Blood Cells

    Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Report Indicates UK £62bn Behind In Global R&D Investment

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    NHS Acquires Potentially Lifesaving Breast Cancer Medication

    Transfusion of The First Patients Lab-Grown Blood Cells

    Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

    $2 Million Gene Therapy Might Become The Standard In The US

    $2 Million Gene Therapy Might Become The Standard In The US

    Cancer Medicine Prices Jump 53% In Five Years In The U.S

    Food And Drug Administration User Fee Has Been Reauthorized

    Cancer Clinical Trials Get A Brand New Platform In Melbourne

    Report Indicates UK £62bn Behind In Global R&D Investment

    Report Indicates UK £62bn Behind In Global R&D Investment

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Americas

T-Bird Pharma Inc. to be British Columbia’s first Health Canada Licensed Publicly Traded Medical Marijuana Company

Yuvraj_pawp by Yuvraj_pawp
9th September 2014
in Americas, News

T-Bird Pharma Inc., a pharmaceutical company focused on developing premium quality medical marijuana products, is pleased to announce that its shares will begin trading on the TSX Venture Exchange on September 9, 2014.  The Company’s wholly-owned subsidiary, Thunderbird Biomedical Inc. (“Thunderbird”), is licensed under the Marihuana for Medical Purposes Regulations (Canada) (“MMPR”) overseen by Health Canada.  T-Bird will be British Columbia’s first publicly traded medical marijuana company.  Thunderbird is one of 13 companies in Canada licensed under the MMPR.

On September 5, 2014, the Company announced the completion of its $3 million equity financing.  The agent on the financing was Richardson GMP Ltd. and the proceeds will enable the Company to bring online two additional grow rooms at their existing Victoria based facility and accelerate expansion to a second larger facility, also located on Vancouver Island, as the Company moves towards commercialization.  Additional updates on the new facility will be available in the coming weeks.

“After spending much of the past year assembling our team and developing our technology driven processes we are excited to be moving the Company forward towards providing a premium quality medical marijuana product to Canadian patients under the MMPR.  Our pharmaceutical grade approach aims to ensure repeatable, scalable and consistent medical marijuana products,” said Rob Gagnon, founder of Thunderbird and CEO of T-Bird.  “Over the next few months we will be working towards further expansion of not only our growing facilities, but also adding key scientific advisors to our team”.

The Company has an existing portfolio of over 60 high grade premium medicinal strains of marijuana, which it refers to internally as “varietals”, and which includes such well known strains as:  Island Honey, Pink Kush and Blue God.  Thunderbird’s focus is on working with BC developed strains.  BC has developed a reputation for expertise in this subject matter and strains that have become synonymous with quality.

“Our business model has been to start with a small facility to perfect our processes which have been architected to be scalable and repeatable.  We believe the market opportunity is only going to grow and we intend to be well positioned to increase capacity while ensuring quality of product” noted incoming Chairman, David Raffa.  Added Raffa, “With the initial financing now done and a strong financial partner in Richardson GMP, we are well positioned to do what is necessary to grow the business.”

Tags: America
Previous Post

Cold Chain Technologies Supports the Boston Marathon® Jimmy Fund Walk Insulated packaging leader is the official sponsor of Refueling Station #6 in Wellesley, Massachusetts

Next Post

Kinex completes acquisition of QuaDPharma

Related Posts

FDA Approvals

NHS Acquires Potentially Lifesaving Breast Cancer Medication

9th November 2022
Clinical Trials

Transfusion of The First Patients Lab-Grown Blood Cells

9th November 2022
Clinical Trials

Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

8th November 2022
India Seeks Better Pharma Market Access In The UK: Official
Facilities & Operation

India Seeks Better Pharma Market Access In The UK: Official

8th November 2022
First Virtual Drug Study Tests 2 Likely Alzheimer Therapies
Clinical Trials

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

7th November 2022
CPhI Pharma Index Shows Unprecedented Global Pharma Optimism
Facilities & Operation

CPhI Pharma Index Shows Unprecedented Global Pharma Optimism

5th November 2022
Next Post

Kinex completes acquisition of QuaDPharma

Latest News

FDA Approvals

NHS Acquires Potentially Lifesaving Breast Cancer Medication

9th November 2022
Clinical Trials

Transfusion of The First Patients Lab-Grown Blood Cells

9th November 2022
Clinical Trials

Bispecific Cancer Drugs, Gene Therapy Advances At Next ASH

8th November 2022
India Seeks Better Pharma Market Access In The UK: Official
Facilities & Operation

India Seeks Better Pharma Market Access In The UK: Official

8th November 2022
First Virtual Drug Study Tests 2 Likely Alzheimer Therapies
Clinical Trials

First Virtual Drug Study Tests 2 Likely Alzheimer Therapies

7th November 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In